TickerLeague

Viatris (VTRS) Stock Buyback History

TTM buyback yield 2.08% · Shareholder yield (TTM) 2.08%.

TTM buyback yield

2.08%

Shareholder yield (TTM)

2.08%

5Y share count change

94.7%

TTM buyback spend

$325.10M

SBC coverage (TTM)

2.65x

YoY change in spend

+100.2%

5Y CAGR of spend

N/A

Peak year (2005)

$1.26B

Cumulative spend

$5.80B

TTM metrics calculated from the four most recent reported quarters, ending (reported ).

Key takeaways

  • Viatris (VTRS) repurchased about $325.10M of stock over the trailing twelve months.
  • Diluted share count is up 94.7% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
  • TTM buyback ÷ stock-based-comp ratio of 2.65× — repurchases more than cover SBC dilution.
  • TTM repurchases used about 28% of free cash flow remaining after dividends.

Buyback context per fiscal year

Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.

YearBuybacksSBCNetShares (dil.)YoY sharesBuyback yield
2025$500.50M$177.70M$322.80M1.17B-1.9%3.49%
2024$250.00M$146.10M$103.90M1.19B-1.1%1.68%
2023$250.00M$180.70M$69.30M1.21B-0.9%1.92%
2022$0.00$116.40M−$116.40M1.22B0.7%
2021$17.40M$111.20M−$93.80M1.21B101.1%0.11%
2020$0.00$79.20M−$79.20M0.60B16.4%
2019$0.00$56.80M−$56.80M0.52B0.0%
2018$432.00M$70.60M$361.40M0.52B-3.8%3.06%
2017$500.20M$74.70M$425.50M0.54B3.1%2.22%
2016$17.50M$88.90M−$71.40M0.52B4.6%0.09%
2015$67.50M$92.80M−$25.30M0.50B25.0%0.24%
2014$27.70M$66.00M−$38.30M0.40B0.9%0.12%
2013$1.00B$47.00M$953.00M0.39B-6.1%5.82%
2012$999.90M$0.00$999.90M0.42B-4.2%
2011$350.00M$0.00$350.00M0.44B33.4%
2010$0.00$0.00$0.000.33B7.2%
2009$0.00$0.00$0.000.31B0.8%
2008$0.00$0.00$0.000.30B18.4%
2007$0.00$0.00$0.000.26B9.8%
2005$1.26B$0.00$1.26B0.23B-14.4%
2004$0.00$0.00$0.000.27B-1.0%
2003$133.09M$0.00$133.09M0.28B

Cash buyback spend (USD) — annual & quarterly history

Trailing-twelve-month and per-period cash repurchases for Viatris (VTRS) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.

Cash buyback spend over time for Viatris (VTRS)

Per-period cash repurchases

Cash buyback spend annual + quarterly history for Viatris (VTRS)

Fiscal yearPeriod endedReportedBuyback SpendYoYYoY change
2025$500.50M+100.2%+$250.50M
2024$250.00M0.0%$0
2023$250.00M+$250.00M
2022$0-100.0%-$17.40M
2021$17.40M+$17.40M
2020$0$0
2019$0-100.0%-$432.00M
2018$432.00M-13.6%-$68.20M
2017$500.20M+2758.3%+$482.70M
2016$17.50M-74.1%-$50.00M
2015$67.50M+143.7%+$39.80M
2014$27.70M-97.2%-$972.30M
2013$1.00B+0.0%+$100,000
2012$999.90M+185.7%+$649.90M
2011$350.00M+$350.00M
2010$0$0
2009$0$0
2008$0$0
2007$0
2005$1.26B+$1.26B
2004$0-100.0%-$133.09M
2003$133.09M

As of the 2025 fiscal year, Viatris (VTRS) reported buyback spend of $500.50M – surged 100.2% year-over-year.

Viatris buyback spend compound annual growth for the 2015–2025 (10 years) window is +22.2%, with the latest reading among the more recent periods of the dataset.

Viatris buyback spend plunged from $1.26B in 2005 to $500.50M in 2025, a 60.2% drawdown.

$1.26B stands as the all-time-high annual buyback spend, posted in 2005, against a low of $0 during 2004.

Viatris (VTRS) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.

Viatris Buyback Spend 2025: $500.50M

Viatris buyback spend in 2025 was $500.50M, surged 100.2% from 2024.

Viatris Buyback Spend 2024: $250.00M

Viatris buyback spend in 2024 was $250.00M, edged up 0.0% from 2023.

Viatris Buyback Spend 2023: $250.00M

Viatris buyback spend in 2023 was $250.00M.

Viatris Buyback Spend 2022: $0

Viatris buyback spend in 2022 was $0, plunged 100.0% below 2021.

Viatris Buyback Spend 2021: $17.40M

Viatris buyback spend in 2021 was $17.40M.

See more financial history for Viatris (VTRS).

Sector peers by buyback spend

Companies in the same sector as Viatris, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group (UNH)$5.54BHealthcare
Merck & Co. (MRK)$5.08BHealthcare
Eli Lilly (LLY)$4.11BHealthcare
Novo Nordisk (NVO)$1.39BHealthcare
AbbVie (ABBV)$980.00MHealthcare
AstraZeneca (AZN)$719.66MHealthcare
Amgen (AMGN)$0Healthcare

Share count history

Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.

Diluted vs basic shares (annual)

Year-over-year change in diluted shares

Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.

Dividend & buyback yield over time

Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.

Buybacks vs stock-based compensation

Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 2.65×.

Capital allocation mix

How Viatris splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.

Buybacks vs dividends (share of cash returned)

Buyback capacity (TTM)

Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.

TTM buybacks vs headroom (FCF − dividends, TTM)28% of headroom

Headroom $1.15B (TTM FCF − TTM dividends, clamped at zero).

Data & methodology

Where do buyback, dividend and compensation figures come from?

Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Viatris's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.

How are diluted shares and yields calculated?

Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.

How is buyback capacity defined?

Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.

Is this investment advice?

No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.

Frequently asked questions

Does Viatris buy back its own stock?

Yes, Viatris (VTRS) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.

How much does Viatris spend on share buybacks?

Trailing twelve months (TTM) buyback spend is about $325.10M (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.

What is Viatris's buyback yield?

TTM buyback yield is about 2.08% (TTM buyback spend divided by market cap at the latest quarter-end in our data).

What is Viatris's shareholder yield?

Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 2.08% combined (TTM-based where available).

Is Viatris diluting shareholders?

Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.

How has Viatris's share count changed?

Diluted weighted average shares changed by about 94.7% over roughly five fiscal years (annual income statement data).

What is Viatris's buyback spend?

Latest reported buyback spend for Viatris (VTRS) is $325.10M (period ending March 31, 2026).

How has Viatris buyback spend changed year-over-year?

Viatris (VTRS) buyback spend changed +100.2% year-over-year on the latest annual filing.

What is the long-term growth rate of Viatris buyback spend?

Viatris (VTRS) buyback spend compound annual growth rate is +22.2% over the most recent 10 years available.

When did Viatris buyback spend hit its highest annual value?

Viatris buyback spend reached its highest annual value of $1.26B in 2005.

What was Viatris buyback spend in 2024?

Viatris (VTRS) buyback spend in 2024 was $250.00M.

What was Viatris buyback spend in 2025?

Viatris (VTRS) buyback spend in 2025 was $500.50M.

Explore more

VTRS Overview

Company profile, financial tools, and key metrics

Explore

VTRS Revenue Counter

Earns $461.78 every second. See per minute, hour, and day.

Explore

VTRS Earnings Counter

Loses −$9.40 per second. See per minute, hour, and day.

Explore

VTRS Economic Scale

Exceeds Rwanda's GDP. Compare with world economies.

Explore

VTRS What If Invested

What if you had invested $1,000? See historical returns from any date.

Explore

VTRS How It Makes Money

Discover visual breakdown of $14.56B in revenue — where it comes from and where it goes.

Explore

VTRS Stock Seasonality

Best and worst months to invest. Historical monthly returns heatmap.

Explore

VTRS Price Target Scenarios

Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.

Explore

VTRS Daily Price Character

Explosive · 44.5% historical win rate (green days). Streaks & record days.

Explore

VTRS Stock Split History

10 splits on record. Dates, ratios, and cumulative multiple.

Explore

VTRS Dividend Profile

Yield: 3.62%. Safety: 5/7. See full history.

Explore

VTRS Dividend Calculator

How much dividend income would $1,000 have earned? Calculate from any date.

Explore

VTRS Dividend Forecast

Project future income with DRIP, growth assumptions, and optional monthly contributions.

Explore

VTRS Dividend Capture

Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).

Explore

VTRS Financials

Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.

Explore